Prellis Biologics

Prellis Biologics, a company developing the tools to create 3D-printed organs, announced a $14.5 million Series B round on Wednesday. Prellis has spent years developing tissue engineering capacity, but has…

Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish